Volume 139, Issue 1, Pages e18 (July 2010)

Slides:



Advertisements
Similar presentations
5/14/ Interim Results from HCV SPRINT-1 Phase 2 Study of Boceprevir Plus Peginterferon alfa-2b/Ribavirin in Treatment-Naïve Subjects with Genotype-1.
Advertisements

Increased Levels of Arginase in Patients With Acute Hepatitis B Suppress Antiviral T Cells Elena Sandalova, Diletta Laccabue, Carolina Boni, Tsunamasa.
Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis.
Volume 146, Issue 2, Pages e1 (February 2014)
American Gastroenterological Association Institute Technical Review on the Management of Acute Diverticulitis  Lisa L. Strate, Anne F. Peery, Ignacio.
Volume 146, Issue 2, Pages e6 (February 2014)
Report of an International Workshop: Roadmap for Management of Patients Receiving Oral Therapy for Chronic Hepatitis B  Emmet B. Keeffe, Stefan Zeuzem,
Volume 139, Issue 4, Pages (October 2010)
Volume 148, Issue 1, Pages e1 (January 2015)
Volume 139, Issue 5, Pages e1 (November 2010)
Volume 153, Issue 3, Pages e7 (September 2017)
Volume 131, Issue 2, Pages (August 2006)
Volume 146, Issue 5, Pages (May 2014)
Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers  Thilo Rattay, Ian P. Dumont, Hauke.
Volume 139, Issue 5, Pages e1 (November 2010)
Covering the Cover Gastroenterology
Volume 139, Issue 4, Pages (October 2010)
Volume 146, Issue 3, Pages e1 (March 2014)
Volume 143, Issue 3, Pages e5 (September 2012)
Peginterferon alfa-2b plus ribavirin for chronic hepatitis
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection  Steven L. Flamm, Eric Lawitz,
Volume 152, Issue 6, Pages e2 (May 2017)
Unusual Case of an Upset Stomach
Volume 146, Issue 3, Pages e3 (March 2014)
Report of an International Workshop: Roadmap for Management of Patients Receiving Oral Therapy for Chronic Hepatitis B  Emmet B. Keeffe, Stefan Zeuzem,
Volume 154, Issue 4, Pages (March 2018)
American Gastroenterological Association Institute Technical Review on the Management of Acute Diverticulitis  Lisa L. Strate, Anne F. Peery, Ignacio.
Volume 155, Issue 5, Pages e2 (November 2018)
Volume 146, Issue 2, Pages e6 (February 2014)
Volume 139, Issue 4, Pages e2 (October 2010)
Volume 143, Issue 5, Pages e6 (November 2012)
A. Sidney Barritt, Michael W. Fried  Gastroenterology 
Volume 146, Issue 2, Pages e1 (February 2014)
Volume 145, Issue 5, Pages e5 (November 2013)
The Combination of Simeprevir and Sofosbuvir Is More Effective Than That of Peginterferon, Ribavirin, and Sofosbuvir for Patients With Hepatitis C–Related.
Anouk Dev, Keyur Patel, Andrew Conrad, Lawrence M. Blatt, John G
Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir  Zobair.
Impact of New Hepatitis C Treatments in Different Regions of the World
Safety and Antiviral Activity of Albinterferon Alfa-2b Dosed Every Four Weeks in Genotype 2/3 Chronic Hepatitis C Patients  Vincent G. Bain, Kelly D.
Volume 139, Issue 4, Pages e4 (October 2010)
Volume 138, Issue 7, Pages (June 2010)
Volume 123, Issue 4, Pages (October 2002)
Volume 151, Issue 5, Pages e1 (November 2016)
Volume 138, Issue 1, Pages e2 (January 2010)
Rafael Esteban, Maria Buti  Gastroenterology 
Hashem El–Serag, Anna S.F. Lok, David L. Thomas  Gastroenterology 
Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients With Chronic Hepatitis C Virus Infection  Elliot.
Volume 140, Issue 7, Pages (June 2011)
Interleukin-28b: A Key Piece of the Hepatitis C Virus Recovery Puzzle
Volume 145, Issue 4, Pages e3 (October 2013)
Volume 150, Issue 2, Pages (February 2016)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Genetic Factors and Hepatitis C Virus Infection
Jeremy P. Dwyer, Patrick Hosking, John Lubel  Gastroenterology 
Volume 149, Issue 6, Pages (November 2015)
Alan Bonder, MD, Nezam H. Afdhal, MD 
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C  Gowtham A. Rao, Prashant K. Pandya  Gastroenterology 
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Volume 143, Issue 3, Pages e5 (September 2012)
Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication  Lauren A. Beste, George.
Volume 150, Issue 7, Pages (June 2016)
Chronic Hepatitis C in Patients With Persistently Normal Alanine Transaminase Levels  Mitchell L. Shiffman, Moisés Diago, Albert Tran, Paul Pockros, Robert.
David J. Gracie, Elspeth A. Guthrie, P. John Hamlin, Alexander C. Ford 
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 5, Pages (November 2010)
Electronic Clinical Challenges and Images in GI
Volume 148, Issue 1, Pages (January 2015)
A Female Patient With Persistent Epigastric Pain for 1 Week
Presentation transcript:

Volume 139, Issue 1, Pages 120-129.e18 (July 2010) Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus  Alexander J. Thompson, Andrew J. Muir, Mark S. Sulkowski, Dongliang Ge, Jacques Fellay, Kevin V. Shianna, Thomas Urban, Nezam H. Afdhal, Ira M. Jacobson, Rafael Esteban, Fred Poordad, Eric J. Lawitz, Jonathan McCone, Mitchell L. Shiffman, Greg W. Galler, William M. Lee, Robert Reindollar, John W. King, Paul Y. Kwo, Reem H. Ghalib, Bradley Freilich, Lisa M. Nyberg, Stefan Zeuzem, Thierry Poynard, David M. Vock, Karen S. Pieper, Keyur Patel, Hans L. Tillmann, Stephanie Noviello, Kenneth Koury, Lisa D. Pedicone, Clifford A. Brass, Janice K. Albrecht, David B. Goldstein, John G. McHutchison  Gastroenterology  Volume 139, Issue 1, Pages 120-129.e18 (July 2010) DOI: 10.1053/j.gastro.2010.04.013 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Median reductions in viral load from baseline on the basis of IL-28B type. (A) Caucasian, (B) African American, and (C) Hispanic patients. Bars represent 25th and 75th percentiles. P < .001 for all pairwise comparisons of median viral load for CC vs CT or TT using the Wilcoxon 2-sample test (see Supplementary Table 1 and 2). Gastroenterology 2010 139, 120-129.e18DOI: (10.1053/j.gastro.2010.04.013) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 Virologic responses on treatment on the basis of IL-28B type and ethnicity. (A) Caucasian, (B) African American, and (C) Hispanic patients. EOTR, end-of-treatment response. Statistical comparisons are presented in Table 2. Gastroenterology 2010 139, 120-129.e18DOI: (10.1053/j.gastro.2010.04.013) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 1 Median reductions in viral load from baseline on the basis of IL-28B genotype in the adherent subset. (A) Caucasians, (B) African Americans, and (C) Hispanics. Bars represent 25th and 75th percentiles. Statistical comparisons are presented in Supplementary Tables 7 and 8. Gastroenterology 2010 139, 120-129.e18DOI: (10.1053/j.gastro.2010.04.013) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 2 Virologic responses on treatment on the basis of IL-28B SNP genotype and ethnicity in the adherent subset. (A) Caucasians, (B) African Americans, and (C) Hispanics. EOTR, end-of-treatment response. Statistical comparisons are presented in Supplementary Tables 7 and 8. Gastroenterology 2010 139, 120-129.e18DOI: (10.1053/j.gastro.2010.04.013) Copyright © 2010 AGA Institute Terms and Conditions